Dollar Amounts
USD (Millions)
Balance sheet data in USD (millions)
Doing some research...
Across 2021–2024 Centene’s balance sheet shows modest net growth but with meaningful year-to-year swings. Total assets moved from $78,375m (2021) down slightly to $76,870m (2022), then rose sharply to $84,641m (2023) before easing to $82,445m (2024). Liabilities followed a similar but slightly more pronounced pattern: $51,353m → $52,633m → $58,685m → $55,935m. Stockholders’ equity declined materially in 2022 (from $26,795m to $24,057m, a ~10.2% drop) then recovered to $25,840m in 2023 and $26,410m in 2024. The balance-sheet mix shows liabilities representing roughly 65.5% of assets in 2021, rising to about 69% in 2022–2023 and easing to ~67.9% in 2024; equity as a share of assets fell from ~34.2% (2021) to ~30.5% (2023) before nudging back to ~32.0% (2024). The 2023 step-up in both assets and liabilities is the most noteworthy fluctuation and likely reflects business expansion drivers common in the managed-care/insurer sector (e.g., increased premium receivables, higher claims/reserve balances, or acquisition-related balance-sheet additions). The rise in liabilities outpacing equity in 2022–2023 increased leverage, while the partial equity recovery in 2023–2024 improved the capital ratio somewhat. These dynamics are consistent with an insurer managing claims reserve and growth cycles; however, the 2022 equity hit warrants review of the income statement (net losses, dividends, or capital actions) for explanation. Note that 2025 data are zeroed/missing, so current-year continuity cannot be assessed.
This analysis is for informational purposes only and does not constitute financial advice or recommendations for any investment decisions. Please consult with a qualified financial professional for personalized guidance.